<p>Naïve adult female BALB/c mice were subcutaneously immunized as described in the text and infected intranasally with 2×10<sup>7</sup> CFU of <i>B. pertussis</i> strain B1917. The bacterial load in the lungs and nose was quantified three (<b>A&C</b>) and seven (<b>B&D</b>) days after challenge. Each symbol represents one mouse. Horizontal lines represents the mean. Dashed lines indicate the lower limit of detection. *<i>p</i><0.05, **<i>p</i><0.005 relative to PBS mice; 2-tailed Mann-Whitney <i>U</i> test.</p
The evaluation of vaccines for human use requires reliable models of infection, that are predictive ...
Uvant (C), twice before intranasal infection. Two hours before challenge, and three and seven days a...
<div><p>(A) Lung colonization by BPSM (solid lines) and BPZE1 (dotted lines) of adult mice infected ...
<p>(A–C) Fold increases in gene expression (relative to mock-infected mice) of KC (A), numbers of ai...
<p>Groups of 3 to 4 C57BL/6 mice were left uninoculated (♦), inoculated with 5×10<sup>5</sup> CFU of...
<p>Groups of 3–4 C57BL/6 mice were vaccinated with (A) 40 µg PRN, (B) 5 µg FHA or (C) 0.5 mL of 1∶5 ...
<p>BALB/c mice were infected intranasally with 5×10<sup>6</sup> CFU of <i>Bordetella</i> strains in ...
Injected with 1/5 human dose (HD) wP, aP, or adjuvant (C), twice before intranasal infection. Three ...
Injected with 1/5 human dose (HD) wP, aP, or adjuvant (C), twice before intranasal infection. Three ...
<p>Protection against B. pertussis in adult (A) and infant mice (B) and (C), or against B. parapertu...
<p>Mice were immunized i.p. twice (0 and 28 days) with PBS, laboratory-prepared Pa in PBS (Ag) or fo...
A murine respiratory challenge model was used to examine the induction of cellular and humoral immun...
<p>The binding of serum (<b>A</b>) and nasal lavage (<b>B</b>) IgG antibodies to Bvg<sup>+</sup> or ...
<p>Naïve (black bars), <i>B. pertussis</i>-vaccinated (white bars), or <i>B. pertussis</i>-convalesc...
<p>Groups of 5 BALB/c mice were i.n. immunized with 10<sup>5 </sup>CFU of BPZE1 or BPZM2e-ΔFHA and c...
The evaluation of vaccines for human use requires reliable models of infection, that are predictive ...
Uvant (C), twice before intranasal infection. Two hours before challenge, and three and seven days a...
<div><p>(A) Lung colonization by BPSM (solid lines) and BPZE1 (dotted lines) of adult mice infected ...
<p>(A–C) Fold increases in gene expression (relative to mock-infected mice) of KC (A), numbers of ai...
<p>Groups of 3 to 4 C57BL/6 mice were left uninoculated (♦), inoculated with 5×10<sup>5</sup> CFU of...
<p>Groups of 3–4 C57BL/6 mice were vaccinated with (A) 40 µg PRN, (B) 5 µg FHA or (C) 0.5 mL of 1∶5 ...
<p>BALB/c mice were infected intranasally with 5×10<sup>6</sup> CFU of <i>Bordetella</i> strains in ...
Injected with 1/5 human dose (HD) wP, aP, or adjuvant (C), twice before intranasal infection. Three ...
Injected with 1/5 human dose (HD) wP, aP, or adjuvant (C), twice before intranasal infection. Three ...
<p>Protection against B. pertussis in adult (A) and infant mice (B) and (C), or against B. parapertu...
<p>Mice were immunized i.p. twice (0 and 28 days) with PBS, laboratory-prepared Pa in PBS (Ag) or fo...
A murine respiratory challenge model was used to examine the induction of cellular and humoral immun...
<p>The binding of serum (<b>A</b>) and nasal lavage (<b>B</b>) IgG antibodies to Bvg<sup>+</sup> or ...
<p>Naïve (black bars), <i>B. pertussis</i>-vaccinated (white bars), or <i>B. pertussis</i>-convalesc...
<p>Groups of 5 BALB/c mice were i.n. immunized with 10<sup>5 </sup>CFU of BPZE1 or BPZM2e-ΔFHA and c...
The evaluation of vaccines for human use requires reliable models of infection, that are predictive ...
Uvant (C), twice before intranasal infection. Two hours before challenge, and three and seven days a...
<div><p>(A) Lung colonization by BPSM (solid lines) and BPZE1 (dotted lines) of adult mice infected ...